BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2947426)

  • 1. Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.
    Braun AR; Barone P; Chase TN
    Adv Exp Med Biol; 1986; 204():151-66. PubMed ID: 2947426
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH; Starr MS
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology of D1 dopamine receptors after neonatal-6-OHDA treatment: relevance to Lesch-Nyhan disease.
    Breese GR; Mueller RA; Napier TC; Duncan GE
    Adv Exp Med Biol; 1986; 204():197-215. PubMed ID: 2947429
    [No Abstract]   [Full Text] [Related]  

  • 4. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
    Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral interactions between muscimol and compounds selective for the D1 and D2 dopamine receptor subtypes.
    Asin KE; Bednarz LM
    Neurosci Lett; 1990 Jun; 113(3):286-91. PubMed ID: 2143274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural differentiation between effects elicited at dopamine D-1 and D-2 receptors in rats.
    Arnt J; Hyttel J
    Clin Neuropharmacol; 1986; 9 Suppl 4():17-9. PubMed ID: 2952268
    [No Abstract]   [Full Text] [Related]  

  • 8. D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects.
    Walters JR; Bergstrom DA; Carlson JH; Chase TN; Braun AR
    Science; 1987 May; 236(4802):719-22. PubMed ID: 2953072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists.
    White FJ; Hu XT; Brooderson RJ
    Eur J Pharmacol; 1990 Dec; 191(3):497-9. PubMed ID: 1982272
    [No Abstract]   [Full Text] [Related]  

  • 10. Diminished D2 dopamine receptor function and the emergence of repetitive jaw movements.
    Rosengarten H; Schweitzer JW; Egawa M; Friedhoff AJ
    Adv Exp Med Biol; 1988; 235():159-67. PubMed ID: 2976249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-1 dopamine receptors and arousal.
    Ongini E
    Adv Exp Med Biol; 1988; 235():169-78. PubMed ID: 2976250
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interactive effects of D1 and D2 dopamine receptor blockade.
    Salama AI; Saller CF
    Adv Exp Med Biol; 1986; 204():137-50. PubMed ID: 2947425
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.
    Braun AR; Chase TN
    Eur J Pharmacol; 1986 Nov; 131(2-3):301-6. PubMed ID: 3493161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D2 receptor agents, but not dopamine D1, modify brain glucose metabolism.
    Palacios JM; Wiederhold KH
    Brain Res; 1985 Feb; 327(1-2):390-4. PubMed ID: 3157422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of dopamine D-1 and D-2 agonists and antagonists in 6-hydroxydopamine-lesioned rats.
    Arnt J
    Psychopharmacology Suppl; 1985; 2():60-1. PubMed ID: 3159011
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat.
    Fletcher GH; Starr MS
    Eur J Pharmacol; 1987 Jun; 138(3):407-11. PubMed ID: 2957221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.